# TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

> **NCT05594563** · PHASE2 · RECRUITING · sponsor: **Emily K. Sims** · enrollment: 81 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** DFMO
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05594563
- **Lead sponsor:** Emily K. Sims
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-14
- **Primary completion:** 2027-12
- **Final completion:** 2028-05
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05594563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05594563, "TArgeting Type 1 Diabetes Using POLyamines (TADPOL)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05594563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*